未登录
分享
收藏
分享
收藏
分享
收藏Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitorsOBSCN表达丢失促进膀胱癌进展,但增强了PD-L1抑制剂的疗效
Wang, Tao; Guo, Tuanjie; Sun, Juanjuan; Zang, Xinyue; Dong, Lei; Zhang, Jian; Chen, Siteng; Chen, Guihua; Ma, Sicong; Zhai, Xinyu; Chu, Chuanmin; Wang, Chaofu; Wang, Xiang; Xu, Dongliang; Tan, Mingyue
分享
收藏
分享
收藏
分享
收藏Precise nano-system-based drug delivery and synergistic therapy against androgen receptorpositive triple-negative breast cancer
Gao, Fangyan; Wu, Yueyao; Wang, Runtian; Yao, Yuhui; Liu, Yiqiu; Fan, Lingling; Xu, Jingtong; Zhang, Jian; Han, Xin; Guan, Xiaoxiang
分享
收藏
分享
收藏
分享
收藏Safety, preliminary efficacy, and pharmacokinetics of HLX26 plus serplulimab in advanced solid tumours: An open-label, dose-escalation phase I study
Wu, Y.; Jing, H.; Zhang, J.; Cao, X.; Li, K.; Liu, Y.; Meng, M.; Li, H.; Kang, W.; Li, J.; Wang, Q.; Zhu, J.
分享
收藏A phase Ia first-in-human study of JS007, a novel anti-CTLA-4 monoclonal antibody, in patients with advanced solid tumors
Zhang, J.; Zhou, C.; Jiang, J.; Liu, H.; Xiang, X.; Wu, G.; Zeng, R.; Kuang, S.
分享
收藏
分享
收藏
分享
收藏
分享
收藏Direct chemical reprogramming of human cord blood erythroblasts to induced megakaryocytes that produce platelets
Qin, Jinhua; Zhang, Jian; Jiang, Jianan; Zhang, Bowen; Li, Jisheng; Lin, Xiaosong; Wang, Sihan; Zhu, Meiqi; Fan, Zeng; Lv, Yang; He, Lijuan; Chen, Lin; Yue, Wen; Li, Yanhua; Pei, Xuetao
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏